Geneva – October 02, 2026 -- The employee partnership owning Gunvor Group Ltd has voted to rename the company Centalion Group Ltd and relocate its corporate headquarters from Cyprus to Singapore, marking the next phase after a December 2025 management buyout.

Nottingham, England – October 02, 2026 -- Quotient Sciences and Copenhagen-based Acesion Pharma have launched a collaboration to apply AI-enhanced formulation development to Acesion's early-stage pipeline of small molecules targeting atrial fibrillation, a condition affecting an estimated 50-60 million people globally.

Kilmarnock – October 02, 2026 -- Copenhagen Infrastructure Partners (CIP) has taken a Financial Investment Decision for Kilmarnock South, a 350 MW/1,400 MWh lithium-ion battery energy storage system in south Ayrshire, Scotland, committing over EUR 270 million (GBP 232 million) through its fourth flagship fund, Copenhagen Infrastructure IV.

Hong Kong – – October 02, 2026 -- Ascletis Pharma Inc. (HKEX: 1672) presented preclinical data showing its ASC36_35FDC injectable combination drove a 24.8% body-weight reduction in a diet-induced obesity rat model on Day 14, outperforming two competitor co-formulations tested under identical dosing conditions.

The data were unveiled in a short oral discussion at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting, held September 28–October 2, 2026, in Milan, Italy.

London – October 02, 2026 -- Samfara has completed the acquisition of Chr. Olesen Synthesis, a Danish manufacturer of controlled-substance active pharmaceutical ingredients, marking the London-based life sciences investment firm's first deal. The transaction sees Samfara buy the business from Chr. Olesen and funds managed by Signet Healthcare Partners, with Chief Executive Thomas Moestrup co-investing alongside the new owner. Financial terms were not disclosed.

Milan – October 02, 2026 -- Hansoh Pharma's dual-biased GLP-1/GIP receptor agonist Olatorepatide (HS-20094) achieved a mean weight loss of 19.3% at Week 48 in the 15 mg dose group of a Phase III Chinese trial, with no plateau observed in the weight-loss curve.

San Clemente, Calif. – October 01, 2026 -- Angelalign Technology Inc. (6699.HK) has launched Pressure Points in the European market, a feature that replaces its existing Torque Ridges and delivers a 25% increase in tooth surface contact in its single pressure point configuration.

London – October 01, 2026 -- Curaleaf International's Que Medical Inhalation Device (QMID) has become the first cannabis inhalation device to secure registration from Australia's Therapeutic Goods Administration, clearing the way for clinicians to prescribe a standardized-dosing device in a market that has treated more than one million patients since 2016.

Pune – October 01, 2026 -- The global water electrolysis market reached USD 7.43 billion in 2025 and is projected to climb to USD 12.66 billion by 2034, a 6.1% CAGR through the forecast period, according to a new report from Maximize Market Research (MMR).

Las Vegas – October 01, 2026 -- Bold Penguin, the Digital Broker for commercial insurance, has entered a global strategic partnership with bolttech, an insurtech operating in 39 countries across four continents, to build a joint commercial and personal lines offering for agents, insurers and embedded partners in the U.S., Europe and Asia.